Basic Information


GTO ID GTC2616
Trial ID NCT04790747
Disease Hematologic Cancer
TherapyCAR-T cell
Treatment CAR-T cells
PhasePhase1|Phase2
Recruitment statusRecruiting
TitleSequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions
Year2021
CountryChina
Company sponsorZhejiang University
Other ID(s)EML-001

Clinical Result

Cohort 1
Administration route intravenous infusion
Pts 50
Age Child, Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph